Centinel Spine launched the Patient Access Program, designed to further expand patient access to the prodisc® L Lumbar Total Disc Replacement (TDR). The program will focus on providing reimbursement support for two-level lumbar disc replacement procedures using prodisc L, the only lumbar TDR product that is FDA-approved for two-level use.
The Patient Access Program was developed with and will be administered in conjunction with Musculoskeletal Clinical Regulatory Advisors, a healthcare industry advisory firm.
“The Patient Access Program is here to provide patients the benefit of covered access to a motion preserving technology clinically proven over the last 30 years,” stated Centinel Spine CEO Steve Murray. “We have been encouraged by the continued progress in expanded coverage for single-level lumbar TDR procedures, and continue work to advance these same coverage benefits for patients with two-level disc disease,” Murray concluded.
Centinel Spine remains the only company with FDA-approved cervical and lumbar total disc replacement devices.
Centinel Spine launched the Patient Access Program, designed to further expand patient access to the prodisc® L Lumbar Total Disc Replacement (TDR). The program will focus on providing reimbursement support for two-level lumbar disc replacement procedures using prodisc L, the only lumbar TDR product that is FDA-approved for two-level...
Centinel Spine launched the Patient Access Program, designed to further expand patient access to the prodisc® L Lumbar Total Disc Replacement (TDR). The program will focus on providing reimbursement support for two-level lumbar disc replacement procedures using prodisc L, the only lumbar TDR product that is FDA-approved for two-level use.
The Patient Access Program was developed with and will be administered in conjunction with Musculoskeletal Clinical Regulatory Advisors, a healthcare industry advisory firm.
“The Patient Access Program is here to provide patients the benefit of covered access to a motion preserving technology clinically proven over the last 30 years,” stated Centinel Spine CEO Steve Murray. “We have been encouraged by the continued progress in expanded coverage for single-level lumbar TDR procedures, and continue work to advance these same coverage benefits for patients with two-level disc disease,” Murray concluded.
Centinel Spine remains the only company with FDA-approved cervical and lumbar total disc replacement devices.
You are out of free articles for this month
Subscribe as a Guest for $0 and unlock a total of 5 articles per month.
You are out of five articles for this month
Subscribe as an Executive Member for access to unlimited articles, THE
ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.
Copy to clipboard 
